Andreas Nikolis News Today

Strong clinical data supporting Alluzience (abobotulinumtoxinA, ABO), the first liquid, ready-to-use neuromodulator as an effective and well-tolerated treatment for glabellar (frown) lines, with

Share this article Share this article MONTREAL, Jan. 8, 2021 /CNW/ - Victoria Park Medispa, a pioneer in the Canadian medical aesthetics industry, is pleased to be the first client for BTL Aesthetics breakthrough laser, the Emsculpt NEO. Emsculpt NEO builds off the legacy of its predecessor EMSCULPT and is the first and only non-invasive body shaping solution to combine two energies, radio-frequency (RF) and High Intensity Focused Electro-Magnetic (HIFEM+) technology.  This simultaneous combi...